These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36083)

  • 1. Metabolic activation of nitrofurantoin--possible implications for carcinogenesis.
    Boyd MR; Stiko AW; Sasame HA
    Biochem Pharmacol; 1979 Mar; 28(5):601-6. PubMed ID: 36083
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic degradations of nitrofurans by rat liver homogenate.
    Akao M; Kuroda K; Miyaki K
    Biochem Pharmacol; 1971 Nov; 20(11):3091-6. PubMed ID: 4399853
    [No Abstract]   [Full Text] [Related]  

  • 3. On the metabolic activation of benz[a]acridine and benz[c]acridine by rat liver and lung microsomes.
    Jacob J; Schmoldt A; Kohbrok W; Raab G; Grimmer G
    Cancer Lett; 1982 Sep; 16(3):297-306. PubMed ID: 7151049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced biotransformation of nitrofurantoin in rats after induction with 3-methylcholanthrene or beta-naphthoflavone.
    Jonen HG; Kaufmann I
    Biochem Pharmacol; 1980 Feb; 29(2):263-6. PubMed ID: 7362639
    [No Abstract]   [Full Text] [Related]  

  • 5. An evaluation of the redox cycling potencies of paraquat and nitrofurantoin in microsomal and lung slice systems.
    Adam A; Smith LL; Cohen GM
    Biochem Pharmacol; 1990 Oct; 40(7):1533-9. PubMed ID: 2222508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of reduction of nitrofurantoin on liver microsomes.
    Leskovac V; Popović M
    Pharmacol Res Commun; 1980 Jan; 12(1):13-27. PubMed ID: 7384160
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the mechanism of nitro reduction by rat liver.
    Kato R; Oshima T; Takanaka A
    Mol Pharmacol; 1969 Sep; 5(5):487-98. PubMed ID: 4390447
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of ratios of covalent binding to total metabolism of the pulmonary toxin, 4-ipomeanol, in vitro in pulmonary and hepatic microsomes, and the effects of pretreatments with phenobarbital or 3-methylcholanthrene.
    Boyd MR; Sasame HA; Franklin RB
    Biochem Biophys Res Commun; 1980 Apr; 93(4):1167-72. PubMed ID: 7396903
    [No Abstract]   [Full Text] [Related]  

  • 9. Superoxide and hydrogen peroxide production and NADPH oxidation stimulated by nitrofurantoin in lung microsomes: possible implications for toxicity.
    Sasame HA; Boyd MR
    Life Sci; 1979 Mar; 24(12):1091-6. PubMed ID: 36538
    [No Abstract]   [Full Text] [Related]  

  • 10. Dibenz [a,j]acridine: distributions of metabolites formed by liver and lung microsomes from control and pretreated rats.
    Gill JH; Duke CC; Ryan AJ; Holder GM
    Carcinogenesis; 1987 Mar; 8(3):425-31. PubMed ID: 3815737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of oxygen by nitrofurantoin in the young chick.
    Peterson FJ; Combs GF; Holtzman JL; Mason RP
    Toxicol Appl Pharmacol; 1982 Aug; 65(1):162-9. PubMed ID: 7147248
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
    Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal oxidative stress induced by NADPH is inhibited by nitrofurantoin redox biotranformation.
    Aracena P; Lazo-Hernández C; Molina-Berríos A; Sepúlveda DR; Reinoso C; Larraín JI; Navarro J; Letelier ME
    Free Radic Res; 2014 Feb; 48(2):129-36. PubMed ID: 23967899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
    Csanády GA; Guengerich FP; Bond JA
    Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of adriamycin by NADPH-cytochrome P-450 reductase, rat liver and heart microsomes and covalent protein binding of metabolites.
    Scheulen ME; Kappus H
    Adv Exp Med Biol; 1981; 136 Pt A():471-85. PubMed ID: 6807062
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitroreduction of 5-nitrofuran derivatives by rat liver xanthine oxidase and reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase.
    Wang CY; Behrens BC; Ichikawa M; Bryan GT
    Biochem Pharmacol; 1974 Dec; 23(24):3395-404. PubMed ID: 4155308
    [No Abstract]   [Full Text] [Related]  

  • 17. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic activation of hepatotoxins and carcinogens: induction by alcohol and drugs].
    Hétu C
    Union Med Can; 1977 May; 106(5):631-5. PubMed ID: 325850
    [No Abstract]   [Full Text] [Related]  

  • 19. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
    Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
    Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotransformation of the carcinogen chrysazin by NADPH-microsome system.
    Kawai K; Mori H; Hisada K; Nozawa Y
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):217-26. PubMed ID: 3786946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.